Skip to main content

Table 1 Baseline characteristics of all patients

From: Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma

Characteristics Cases Percentage (%)
Sex 310  
 Male 174 56.1
 Female 136 43.9
Age at operation (years)
 < 50 208 67.1
 ≥ 50 102 32.9
Performance status
 0 237 76.5
 ≥ 1 73 23.5
Body mass index (kg/m2)
 < 18.5 42 13.5
 ≥ 18.5 to< 25.0 208 67.1
 ≥ 25.0 60 19.4
Pathological types
 Fibrosarcoma 59 19.0
 liposarcoma 37 11.9
 Undifferentiated pleomorphic sarcoma/MFH 78 25.2
 Leiomyosarcoma 17 5.5
 Synovial sarcoma 40 12.9
 Rhabdomyosarcoma 19 6.1
 Alveolar soft part sarcoma 9 2.9
 Angiosarcoma 8 2.6
 Malignant peripheral nerve sheath tumor 15 4.8
 Mesenchymal chondrosarcoma 8 2.6
 Others 20 6.5
Tumor size (cm)
 < 5 143 46.1
 ≥ 5 167 53.9
Tumor site
 Upper extremity 35 11.3
 Lower extremity 82 26.5
 Thoracic/trunk/abdominal wall 91 29.4
 Intra-abdominal 48 15.5
 Head/neck 48 15.5
 Others 6 1.9
Tumor depth
 Superficial 127 41.0
 Deep 183 59.0
Tumor grade
 G1 82 26.5
 G2 119 38.4
 G3 80 25.8
 Missing 29 9.4
Surgical margin
 R0 279 95.2
 R1 9 3.1
 R2 3 1.0
 Rx 2 0.7
AJCC stage
 IA + IB 83 26.8
 IIA + IIB 141 45.5
 III + IV 62 20.0
 Missing 24 7.1
NLR
 < 2.51 214 69.0
 ≥ 2.51 96 31.0
PLR
 < 191.1 265 85.5
 ≥ 191.1 45 14.5
FAR
 < 0.0726 176 56.8
 ≥ 0.0726 124 43.2
End-point
 Alive 212 68.4
 Dead 98 31.6
Recurrence
 YES 112 36.1
 NO 198 63.9
Metastasis
 YES 61 19.7
 NO 249 80.3
Adjuvant therapy
 None 257 82.9
 Chemotherapy 14 4.5
 Radiotherapy 16 5.2
 Combined chemoradiotherapy 2 0.6
 Unknown 21 6.8